PSVT

on 28.1.07 with 0 comments



Paroxysmal supraventricular tachyarrthymias (PSVT) may be managed, depending upon clinical presentation, by increasing the vagal tone at the AV node

  • Valsalva maneuver

  • Alpha-adrenergic receptor agonist administration

  • digoxin administration

  • by administration of drugs that reduce AV transmission:

    • Adenosine , verapamil , diltiazem , esmolol or DC cardioversion.

      • Adenosine (Adenocard)

        • Effects mediated through G protein-coupled adenosine receptor.

        • Activates acetylcholine-sensitive K+ current in the atrium and sinus and A-V node.

        • Decreases action potential duration, reduces automaticity

        • Increases A-V nodal refractoriness

        • Rapidly terminates re-entrant supraventricular arrhythmias (I.V)

      • Verapamil (Isoptin, Calan) & Diltiazem (Cardiazem)

        • Blocks cardiac calcium channels in slow response tissues, such as the sinus and AV nodes.

        • Useful in treating AV reentrant tachyarrhythmias and in management of high ventricular rates secondary to atrial flutter or fibrillation.

        • Major adverse effect (i.v. administration) is hypotension. Heart block or sinus bradycardia can also occur.

      • Esmolol (Brevibloc)

        • Esmolol is a very short acting, cardioselective beta-adrenergic receptor antagonist.

        • i.v. administration is used for rapid beta-receptor blockade in treatment of atrial fibrillation with high ventricular following rates.

        • Antiarrhythmic effects are due mainly to beta-adrenergic receptor blockade. Normally, sympathetic drive results in increased in Ca2+ ,K+and Cl- currents.

        • Increased sympathetic tone also increases phase 4 depolarization (heart rate goes up), and increases DAD (delayed afterdepolarizations) and EAD (early afterdepolarization) mediated arrhythmias. These effects are blocked by beta-adrenergic receptor blockers.

        • Beta-adrenergic receptor blockers

          • increase AV conduction time

          • increase AV nodal refractoriness, thereby helping to terminate nodal reentrant arrhythmias

Category: Pharmacology Notes

POST COMMENT

0 comments:

Post a Comment